{"_links": {"priorVersion": {"href": "/mdr/ct/packages/ddfct-2023-09-29", "title": "DDF Controlled Terminology Package 55 Effective 2023-09-29", "type": "Terminology"}, "self": {"href": "/mdr/ct/packages/ddfct-2023-12-15", "title": "DDF Controlled Terminology Package 56 Effective 2023-12-15", "type": "Terminology"}}, "codelists": [{"conceptId": "C188714", "definition": "A terminology value set relevant to the attributes of the activity.", "name": "DDF Activity Attribute Terminology", "preferredTerm": "CDISC DDF Activity Attribute Terminology", "submissionValue": "DDF Activity Attribute Terminology", "synonyms": ["DDF Activity Attribute Terminology"], "terms": [{"conceptId": "C70960", "definition": "The textual representation of the study activity.", "preferredTerm": "Clinical Study Activity Description", "submissionValue": "Clinical Study Activity Description"}, {"conceptId": "C188842", "definition": "The literal identifier (i.e., distinctive designation) of the clinical study activity.", "preferredTerm": "Clinical Study Activity Name", "submissionValue": "Clinical Study Activity Name"}, {"conceptId": "C201308", "definition": "The explanation for why the study activity is subject to or dependent upon something else.", "preferredTerm": "Study Activity is Conditional Reason", "submissionValue": "Study Activity is Conditional Reason"}, {"conceptId": "C201307", "definition": "An indication as to whether the study activity is subject to or dependent upon something else.", "preferredTerm": "Study Activity is Conditional Indicator", "submissionValue": "Study Activity is Conditional"}, {"conceptId": "C201310", "definition": "The explanation for why the study activity is available to be performed but is not obligatory.", "preferredTerm": "Study Activity is Optional Reason", "submissionValue": "Study Activity is Optional Reason"}, {"conceptId": "C201309", "definition": "An indication as to whether the study activity is available to be performed but is not obligatory.", "preferredTerm": "Study Activity is Optional Indicator", "submissionValue": "Study Activity is Optional"}]}, {"conceptId": "C201253", "definition": "A terminology value set relevant to the attributes of the address.", "name": "DDF Address Attribute Terminology", "preferredTerm": "CDISC DDF Address Attribute Terminology", "submissionValue": "DDF Address Attribute Terminology", "synonyms": ["DDF Address Attribute Terminology"], "terms": [{"conceptId": "C201311", "definition": "A standardized representation of the complete set of components denoting the physical address of the person, business, building, or organization.", "preferredTerm": "Address Full Text", "submissionValue": "Address Full Text"}, {"conceptId": "C25690", "definition": "The street name and number, building number, apartment or unit number, or post office box number where an entity is physically located.", "preferredTerm": "Street Address", "submissionValue": "Address Line"}, {"conceptId": "C25160", "definition": "A relatively large and/or densely populated area of human habitation with administrative or legal status that may be specified as a component of a postal address.", "preferredTerm": "City", "submissionValue": "City"}, {"conceptId": "C25464", "definition": "A sovereign nation occupying a distinct territory and ruled by an autonomous government.", "preferredTerm": "Country", "submissionValue": "Country"}, {"conceptId": "C176229", "definition": "An administrative or territorial division of a city, town, county, parish, state, country, or other locality based on a shared characteristic.", "preferredTerm": "District", "submissionValue": "District"}, {"conceptId": "C25621", "definition": "An alphanumeric code assigned to a mail delivery area.", "preferredTerm": "Postal Code", "submissionValue": "Postal Code"}, {"conceptId": "C87194", "definition": "A sub-division of a country that forms part of a federal union. States are usually, but not always, more autonomous than provinces and may have different laws from the central government.", "preferredTerm": "State", "submissionValue": "State"}]}, {"conceptId": "C188720", "definition": "A terminology value set relevant to the attributes of the analysis population.", "name": "DDF Analysis Population Attribute Terminology", "preferredTerm": "CDISC DDF Analysis Population Attribute Terminology", "submissionValue": "DDF Analysis Population Attribute Terminology", "synonyms": ["DDF Analysis Population Attribute Terminology"], "terms": [{"conceptId": "C188854", "definition": "The textual representation of the study population for analysis.", "preferredTerm": "Target Study Population for Analysis Description", "submissionValue": "Target Study Population for Analysis Description"}]}, {"conceptId": "C201254", "definition": "A terminology value set relevant to the attributes of the biomedical concept.", "name": "DDF Biomedical Concept Attribute Terminology", "preferredTerm": "CDISC DDF Biomedical Concept Attribute Terminology", "submissionValue": "DDF Biomedical Concept Attribute Terminology", "synonyms": ["DDF Biomedical Concept Attribute Terminology"], "terms": [{"conceptId": "C201312", "definition": "The literal identifier (i.e., distinctive designation) of the biomedical concept.", "preferredTerm": "Biomedical Concept Name", "submissionValue": "Biomedical Concept Name"}, {"conceptId": "C201313", "definition": "A citation to an authoritative source for a biomedical concept.", "preferredTerm": "Biomedical Concept Reference", "submissionValue": "Biomedical Concept Reference"}, {"conceptId": "C201314", "definition": "A word or an expression that serves as a figurative, symbolic, or exact substitute for a biomedical concept, and which has the same meaning.", "preferredTerm": "Biomedical Concept Synonym", "submissionValue": "Biomedical Concept Synonym"}]}, {"conceptId": "C201255", "definition": "A terminology value set relevant to the attributes of the biomedical concept category.", "name": "DDF Biomedical Concept Category Attribute Terminology", "preferredTerm": "CDISC DDF Biomedical Concept Category Attribute Terminology", "submissionValue": "DDF Biomedical Concept Category Attribute Terminology", "synonyms": ["DDF Biomedical Concept Category Attribute Terminology"], "terms": [{"conceptId": "C201315", "definition": "A symbol or combination of symbols which is assigned to the biomedical concept category.", "preferredTerm": "Biomedical Concept Category Code", "submissionValue": "Biomedical Concept Category Code"}, {"conceptId": "C201316", "definition": "The textual representation of the biomedical concept category.", "preferredTerm": "Biomedical Concept Category Description", "submissionValue": "Biomedical Concept Category Description"}, {"conceptId": "C201317", "definition": "The literal identifier (i.e., distinctive designation) of the biomedical concept category.", "preferredTerm": "Biomedical Concept Category Name", "submissionValue": "Biomedical Concept Category Name"}]}, {"conceptId": "C201256", "definition": "A terminology value set relevant to the attributes of the biomedical concept property.", "name": "DDF Biomedical Concept Property Attribute Terminology", "preferredTerm": "CDISC DDF Biomedical Concept Property Attribute Terminology", "submissionValue": "DDF Biomedical Concept Property Attribute Terminology", "synonyms": ["DDF Biomedical Concept Property Attribute Terminology"], "terms": [{"conceptId": "C201318", "definition": "A concept unique identifier assigned to a biomedical concept property that points to the meaning of that biomedical concept property.", "preferredTerm": "Biomedical Concept Property Concept Code", "submissionValue": "Biomedical Concept Property Concept Code"}, {"conceptId": "C202496", "definition": "An indication as to whether the biomedical concept property is activated for use within a given usage context for a biomedical concept.", "preferredTerm": "Biomedical Concept Property Enabled Indicator", "submissionValue": "Biomedical Concept Property Enabled Indicator"}, {"conceptId": "C202494", "definition": "The literal identifier (i.e., distinctive designation) of the biomedical concept property.", "preferredTerm": "Biomedical Concept Property Name", "submissionValue": "Biomedical Concept Property Name"}, {"conceptId": "C202495", "definition": "An indication as to whether the biomedical concept property is required.", "preferredTerm": "Biomedical Concept Property Required Indicator", "submissionValue": "Biomedical Concept Property Required Indicator"}, {"conceptId": "C201319", "definition": "The structural format of the biomedical concept property response value. The datatype is carried in the attribute and influences the set of allowable values the attribute may assume. (After HL7)", "preferredTerm": "Biomedical Concept Property Response Data Type", "submissionValue": "Biomedical Concept Property Response Data Type"}]}, {"conceptId": "C201257", "definition": "A terminology value set relevant to the attributes of the biomedical concept surrogate.", "name": "DDF Biomedical Concept Surrogate Attribute Terminology", "preferredTerm": "CDISC DDF Biomedical Concept Surrogate Attribute Terminology", "submissionValue": "DDF Biomedical Concept Surrogate Attribute Terminology", "synonyms": ["DDF Biomedical Concept Surrogate Attribute Terminology"], "terms": [{"conceptId": "C201320", "definition": "The textual representation of the biomedical concept surrogate.", "preferredTerm": "Biomedical Concept Surrogate Description", "submissionValue": "Biomedical Concept Surrogate Description"}, {"conceptId": "C201321", "definition": "A citation to an authoritative source for a biomedical concept surrogate.", "preferredTerm": "Biomedical Concept Surrogate Reference", "submissionValue": "Biomedical Concept Surrogate Reference"}]}, {"conceptId": "C188699", "definition": "A terminology value set relevant to the attributes of the clinical study.", "name": "DDF Clinical Study Attribute Terminology", "preferredTerm": "CDISC DDF Clinical Study Attribute Terminology", "submissionValue": "DDF Clinical Study Attribute Terminology", "synonyms": ["DDF Clinical Study Attribute Terminology"], "terms": [{"conceptId": "C201322", "definition": "A therapeutic area classification based on the structure and operations of the business unit.", "preferredTerm": "Business Therapeutic Areas", "submissionValue": "Business Therapeutic Areas"}, {"conceptId": "C94108", "definition": "A word or words formed from the beginning letters or a combination of syllables and letters of a compound term, which identifies a clinical study.", "preferredTerm": "Study Protocol Version Acronym", "submissionValue": "Study Acronym", "synonyms": ["Trial Acronym"]}, {"conceptId": "C94122", "definition": "A statement describing the overall rationale of the study. This field describes the contribution of this study to product development, i.e., what knowledge is being contributed from the conduct of this study.", "preferredTerm": "Study Protocol Version Purpose Statement", "submissionValue": "Study Rationale", "synonyms": ["Study Purpose"]}, {"conceptId": "C49802", "definition": "The sponsor-defined name of the clinical study.", "preferredTerm": "Trial Title", "submissionValue": "Study Title", "synonyms": ["Official Study Title", "Study Title", "Trial Title"]}, {"conceptId": "C142175", "definition": "The nature of the investigation for which study information is being collected. (After clinicaltrials.gov)", "preferredTerm": "Study Type", "submissionValue": "Study Type Classification", "synonyms": ["Study Type", "Study Type Classification"]}, {"conceptId": "C188816", "definition": "A plan at a particular point in time for a study.", "preferredTerm": "Study Version", "submissionValue": "Study Version"}, {"conceptId": "C48281", "definition": "A step in the clinical research and development of a therapy from initial clinical trials to post-approval studies. NOTE: Clinical trials are generally categorized into four (sometimes five) phases. A therapeutic intervention may be evaluated in two or more phases simultaneously in different trials, and some trials may overlap two different phases. [21 CFR section 312.21; After ICH Topic E8 NOTE FOR GUIDANCE ON GENERAL CONSIDERATIONS FOR CLINICAL TRIALS, CPMP/ICH/291/95 March 1998]", "preferredTerm": "Trial Phase", "submissionValue": "Trial Phase", "synonyms": ["Trial Phase", "Trial Phase Classification"]}]}, {"conceptId": "C188722", "definition": "A terminology value set relevant to the attributes of the code.", "name": "DDF Code Attribute Terminology", "preferredTerm": "CDISC DDF Code Attribute Terminology", "submissionValue": "DDF Code Attribute Terminology", "synonyms": ["DDF Code Attribute Terminology"], "terms": [{"conceptId": "C188859", "definition": "The literal identifier (i.e., distinctive designation) of the system used to assign and/or manage codes.", "preferredTerm": "Code System Name", "submissionValue": "Code System Name"}, {"conceptId": "C188868", "definition": "The version of the code system.", "preferredTerm": "Coding System Version", "submissionValue": "Code System Version"}, {"conceptId": "C188858", "definition": "The literal value of a code.", "preferredTerm": "Code Value", "submissionValue": "Code Value"}, {"conceptId": "C188861", "definition": "Standardized or dictionary-derived human readable text associated with a code.", "preferredTerm": "Decode Text", "submissionValue": "Decode"}]}, {"conceptId": "C188713", "definition": "A terminology value set relevant to the attributes of the encounter.", "name": "DDF Encounter Attribute Terminology", "preferredTerm": "CDISC DDF Encounter Attribute Terminology", "submissionValue": "DDF Encounter Attribute Terminology", "synonyms": ["DDF Encounter Attribute Terminology"], "terms": [{"conceptId": "C188836", "definition": "The textual representation of the protocol-defined clinical encounter.", "preferredTerm": "Clinical Encounter Description", "submissionValue": "Clinical Encounter Description"}, {"conceptId": "C171010", "definition": "The literal identifier (i.e., distinctive designation) for a protocol-defined clinical encounter.", "preferredTerm": "Clinical Encounter Name", "submissionValue": "Clinical Encounter Name"}, {"conceptId": "C188839", "definition": "A characterization or classification of contact between subject/patient and healthcare practitioner/researcher, during which an assessment or activity is performed.", "preferredTerm": "Clinical Encounter Type", "submissionValue": "Clinical Encounter Type"}, {"conceptId": "C188841", "definition": "The means by which an interaction occurs between the subject/participant and person or entity (e.g., a device).", "preferredTerm": "Contact Mode", "submissionValue": "Contact Mode"}, {"conceptId": "C188840", "definition": "The environment/setting where the event, intervention, or finding occurred.", "preferredTerm": "Environmental Setting", "submissionValue": "Environmental Setting"}, {"conceptId": "C188838", "definition": "A system identifier assigned to a clinical encounter that occurs immediately after the current clinical encounter.", "preferredTerm": "Next Clinical Encounter Identifier", "submissionValue": "Next Encounter Identifier"}, {"conceptId": "C188837", "definition": "A system identifier assigned to a clinical encounter that occurs immediately prior to the current clinical encounter.", "preferredTerm": "Previous Clinical Encounter Identifier", "submissionValue": "Previous Encounter Identifier"}]}, {"conceptId": "C188708", "definition": "A terminology value set relevant to the attributes of the endpoint.", "name": "DDF Endpoint Attribute Terminology", "preferredTerm": "CDISC DDF Endpoint Attribute Terminology", "submissionValue": "DDF Endpoint Attribute Terminology", "synonyms": ["DDF Endpoint Attribute Terminology"], "terms": [{"conceptId": "C188824", "definition": "The textual representation of the study endpoint.", "preferredTerm": "Study Endpoint Description", "submissionValue": "Study Endpoint Description"}, {"conceptId": "C188826", "definition": "A characterization or classification of the study endpoint that determines its category of importance relative to other study endpoints.", "preferredTerm": "Study Endpoint Level", "submissionValue": "Study Endpoint Level"}, {"conceptId": "C188825", "definition": "The textual representation of the study endpoint purpose.", "preferredTerm": "Study Endpoint Purpose Description", "submissionValue": "Study Endpoint Purpose Description"}]}, {"conceptId": "C188698", "definition": "A terminology value set relevant to the entities within the CDISC digital data flow (DDF) model.", "name": "DDF Entity Terminology", "preferredTerm": "CDISC DDF Entities Terminology", "submissionValue": "DDF Entity Terminology", "synonyms": ["DDF Entity Terminology"], "terms": [{"conceptId": "C25407", "definition": "A standardized representation of the location of a person, business, building, or organization. (NCI)", "preferredTerm": "Address", "submissionValue": "Address"}, {"conceptId": "C201344", "definition": "An alternative symbol or combination of symbols which is assigned to the members of a collection.", "preferredTerm": "Alias Code", "submissionValue": "Alias Code"}, {"conceptId": "C201346", "definition": "A grouping of biomedical concepts based on some commonality or by user defined characteristics.", "preferredTerm": "Biomedical Concept Category", "submissionValue": "Biomedical Concept Category"}, {"conceptId": "C202493", "definition": "A characteristic from a set of characteristics used to define a biomedical concept.", "preferredTerm": "Biomedical Concept Property", "submissionValue": "Biomedical Concept Property"}, {"conceptId": "C201345", "definition": "A unit of biomedical knowledge created from a unique combination of characteristics that include implementation details like variables and terminologies, used as building blocks for standardized, hierarchically structured clinical research information.", "preferredTerm": "Biomedical Concept", "submissionValue": "Biomedical Concept"}, {"conceptId": "C142427", "definition": "Contact between subject/patient and healthcare practitioner/researcher, during which an assessment or activity is performed. Contact may be physical or virtual.", "preferredTerm": "Clinical Encounter", "submissionValue": "Clinical Encounter"}, {"conceptId": "C15206", "definition": "A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. [ClinicalTrials.gov] See also clinical trial. (CDISC Glossary)", "preferredTerm": "Clinical Study", "submissionValue": "Clinical Study"}, {"conceptId": "C25162", "definition": "A symbol or combination of symbols which is assigned to the members of a collection.", "preferredTerm": "Code", "submissionValue": "Code"}, {"conceptId": "C188813", "definition": "A precise description of the treatment effect reflecting the clinical question posed by a given clinical trial objective. It summarises at a population level what the outcomes would be in the same patients under different treatment conditions being compared. (ICH E9 R1 Addendum)", "preferredTerm": "Estimand", "submissionValue": "Estimand"}, {"conceptId": "C41161", "definition": "The drug, device, therapy, or process under investigation in a clinical study that is believed to have an effect on outcomes of interest in a study (e.g., health-related quality of life, efficacy, safety, pharmacoeconomics). [After https://grants.nih.gov/grants/policy/faq_clinical_trial_definition.htm#5224]", "preferredTerm": "Protocol Agent", "submissionValue": "Experimental Intervention", "synonyms": ["Investigational Interventional", "Investigational Therapy or Treatment"]}, {"conceptId": "C188815", "definition": "An event(s) occurring after treatment initiation that affects either the interpretation or the existence of the measurements associated with the clinical question of interest. (ICH E9 Addendum on Estimands)", "preferredTerm": "Intercurrent Event", "submissionValue": "Intercurrent Event"}, {"conceptId": "C19711", "definition": "A formalized group of persons or other organizations collected together for a common purpose (such as administrative, legal, political) and the infrastructure to carry out that purpose. (BRIDG)", "preferredTerm": "Professional Organization or Group", "submissionValue": "Organization"}, {"conceptId": "C98769", "definition": "Any activity performed by manual and/or instrumental means for the purpose of diagnosis, assessment, therapy, prevention, or palliative care.", "preferredTerm": "Physical Medical Procedure", "submissionValue": "Procedure", "synonyms": ["Medical Procedure"]}, {"conceptId": "C201347", "definition": "A symbol or combination of symbols representing the response to the question.", "preferredTerm": "Response Code", "submissionValue": "Response Code"}, {"conceptId": "C201349", "definition": "To go out of or leave the schedule timeline.", "preferredTerm": "Schedule Timeline Exit", "submissionValue": "Schedule Timeline Exit"}, {"conceptId": "C201348", "definition": "A chronological schedule of planned temporal events.", "preferredTerm": "Schedule Timeline", "submissionValue": "Schedule Timeline"}, {"conceptId": "C201350", "definition": "A scheduled occurrence of an activity event.", "preferredTerm": "Scheduled Activity Instance", "submissionValue": "Scheduled Activity Instance"}, {"conceptId": "C201351", "definition": "A scheduled occurrence of a decision event.", "preferredTerm": "Scheduled Decision Instance", "submissionValue": "Scheduled Decision Instance"}, {"conceptId": "C201299", "definition": "A scheduled occurrence of a temporal event.", "preferredTerm": "Scheduled Instance", "submissionValue": "Scheduled Instance"}, {"conceptId": "C71473", "definition": "An action, undertaking, or event, which is anticipated to be performed or observed, or was performed or observed, according to the study protocol during the execution of the study.", "preferredTerm": "Study Activity", "submissionValue": "Study Activity"}, {"conceptId": "C174447", "definition": "A planned pathway assigned to the subject as they progress through the study, usually referred to by a name that reflects one or more treatments, exposures, and/or controls included in the path.", "preferredTerm": "Study Arm", "submissionValue": "Study Arm", "synonyms": ["Arm"]}, {"conceptId": "C188810", "definition": "A partitioning of a study arm into individual pieces, which are associated with an epoch and any number of sequential elements within that epoch.", "preferredTerm": "Study Design Cell", "submissionValue": "Study Design Cell"}, {"conceptId": "C142735", "definition": "A basic building block for time within a clinical study comprising the following characteristics: a description of what happens to the subject during the element; a definition of the start of the element; a rule for ending the element.", "preferredTerm": "Trial Design Element", "submissionValue": "Study Design Element"}, {"conceptId": "C15320", "definition": "A plan detailing how a study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and informing the statistical approach.", "preferredTerm": "Study Design", "submissionValue": "Study Design"}, {"conceptId": "C25212", "definition": "A defined variable intended to reflect an outcome of interest that is statistically analyzed to address a particular research question. NOTE: A precise definition of an endpoint typically specifies the type of assessments made, the timing of those assessments, the assessment tools used, and possibly other details, as applicable, such as how multiple assessments within an individual are to be combined. [After BEST Resource] (CDISC Glossary)", "preferredTerm": "End Point", "submissionValue": "Study Endpoint"}, {"conceptId": "C71738", "definition": "A named time period defined in the protocol, wherein a study activity is specified and unchanging throughout the interval, to support a study-specific purpose.", "preferredTerm": "Clinical Trial Epoch", "submissionValue": "Study Epoch"}, {"conceptId": "C83082", "definition": "A sequence of characters used to identify, name, or characterize the study.", "preferredTerm": "Study Identifier", "submissionValue": "Study Identifier"}, {"conceptId": "C142450", "definition": "The reason for performing a study in terms of the scientific questions to be answered by the analysis of data collected during the study.", "preferredTerm": "Clinical Trial Objective", "submissionValue": "Study Objective"}, {"conceptId": "C93490", "definition": "A plan at a particular point in time for a formal investigation to assess the utility, impact, pharmacological, physiological, and/or psychological effects of a particular treatment, procedure, drug, device, biologic, food product, cosmetic, care plan, or subject characteristic. (BRIDG)", "preferredTerm": "Study Protocol Version", "submissionValue": "Study Protocol Version"}, {"conceptId": "C188814", "definition": "A target study population on which an analysis is performed. These may be represented by the entire study population, a subgroup defined by a particular characteristic measured at baseline, or a principal stratum defined by the occurrence (or non-occurrence, depending on context) of a specific intercurrent event. (ICH E9 R1 Addendum)", "preferredTerm": "Target Study Population for Analysis", "submissionValue": "Target Study Population for Analysis"}, {"conceptId": "C142728", "definition": "The population within the general population for which the study results can be generalized.", "preferredTerm": "Target Study Population", "submissionValue": "Target Study Population", "synonyms": ["Target Population"]}, {"conceptId": "C80484", "definition": "The chronological relationship between temporal events.", "preferredTerm": "Timing", "submissionValue": "Timing"}, {"conceptId": "C82567", "definition": "A guide that governs the allocation of subjects to operational options at a discrete decision point or branch (e.g., assignment to a particular arm, discontinuation) within a clinical trial plan.", "preferredTerm": "Transition Rule", "submissionValue": "Transition Rule"}, {"conceptId": "C112038", "definition": "The textual representation of the condition, disease or disorder that the clinical trial is intended to investigate or address.", "preferredTerm": "Trial Indication", "submissionValue": "Trial Disease/Condition Indication Description", "synonyms": ["Trial Disease/Condition Indication", "Trial Disease/Condition Indication Description"]}]}, {"conceptId": "C188719", "definition": "A terminology value set relevant to the attributes of the estimand.", "name": "DDF Estimand Attribute Terminology", "preferredTerm": "CDISC DDF Estimand Attribute Terminology", "submissionValue": "DDF Estimand Attribute Terminology", "synonyms": ["DDF Estimand Attribute Terminology"], "terms": [{"conceptId": "C188853", "definition": "A synopsis of the clinical endpoint of interest within the analysis target study population.", "preferredTerm": "Population-Level Summary", "submissionValue": "Population-Level Summary"}, {"conceptId": "C201323", "definition": "The variable identified as the focus for developing the estimand.", "preferredTerm": "Variable of Interest for the Estimand", "submissionValue": "Variable of Interest"}]}, {"conceptId": "C188705", "definition": "A terminology value set relevant to the attributes of the disease indication.", "name": "DDF Indication Attribute Terminology", "preferredTerm": "CDISC DDF Indication Attribute Terminology", "submissionValue": "DDF Indication Attribute Terminology", "synonyms": ["DDF Indication Attribute Terminology"], "terms": [{"conceptId": "C188822", "definition": "A short sequence of characters that represents the disease indication.", "preferredTerm": "Disease Indication Code", "submissionValue": "Disease Indication Code"}, {"conceptId": "C112038", "definition": "The textual representation of the condition, disease or disorder that the clinical trial is intended to investigate or address.", "preferredTerm": "Trial Indication", "submissionValue": "Trial Disease/Condition Indication Description", "synonyms": ["Trial Disease/Condition Indication", "Trial Disease/Condition Indication Description"]}]}, {"conceptId": "C188721", "definition": "A terminology value set relevant to the attributes of the intercurrent event.", "name": "DDF Intercurrent Event Attribute Terminology", "preferredTerm": "CDISC DDF Intercurrent Event Attribute Terminology", "submissionValue": "DDF Intercurrent Event Attribute Terminology", "synonyms": ["DDF Intercurrent Event Attribute Terminology"], "terms": [{"conceptId": "C188856", "definition": "The textual representation of the intercurrent event.", "preferredTerm": "Intercurrent Event Description", "submissionValue": "Intercurrent Event Description"}, {"conceptId": "C188855", "definition": "The literal identifier (i.e., distinctive designation) of the intercurrent event.", "preferredTerm": "Intercurrent Event Name", "submissionValue": "Intercurrent Event Name"}, {"conceptId": "C188857", "definition": "A textual description of the planned strategy to manage and/or mitigate intercurrent events.", "preferredTerm": "Intercurrent Event Strategy", "submissionValue": "Intercurrent Event Strategy"}]}, {"conceptId": "C188704", "definition": "A terminology value set relevant to the attributes of the investigational interventions.", "name": "DDF Investigational Interventions Attribute Terminology", "preferredTerm": "CDISC DDF Investigational Interventions Attribute Terminology", "submissionValue": "DDF Investigational Interventions Attribute Terminology", "synonyms": ["DDF Investigational Interventions Attribute Terminology"], "terms": [{"conceptId": "C177931", "definition": "The textual representation of the study intervention.", "preferredTerm": "Intervention Description", "submissionValue": "Intervention Description"}, {"conceptId": "C188821", "definition": "A short sequence of characters that represents the investigational intervention.", "preferredTerm": "Investigational Intervention Code", "submissionValue": "Investigational Intervention Code"}]}, {"conceptId": "C188707", "definition": "A terminology value set relevant to the attributes of the objective.", "name": "DDF Objective Attribute Terminology", "preferredTerm": "CDISC DDF Objective Attribute Terminology", "submissionValue": "DDF Objective Attribute Terminology", "synonyms": ["DDF Objective Attribute Terminology"], "terms": [{"conceptId": "C94090", "definition": "The textual representation of the study objective. (BRIDG)", "preferredTerm": "Study Objective Description", "submissionValue": "Study Objective Description"}, {"conceptId": "C188823", "definition": "A characterization or classification of the study objective that determines its category of importance relative to other study objectives.", "preferredTerm": "Study Objective Level", "submissionValue": "Study Objective Level"}]}, {"conceptId": "C188702", "definition": "A terminology value set relevant to the attributes of the organization.", "name": "DDF Organization Attribute Terminology", "preferredTerm": "CDISC DDF Organization Attribute Terminology", "submissionValue": "DDF Organization Attribute Terminology", "synonyms": ["DDF Organization Attribute Terminology"], "terms": [{"conceptId": "C188819", "definition": "The name of the organization that provides the identifier for the entity.", "preferredTerm": "Identifier Provider Organization Name", "submissionValue": "Identifier Provider Organization Name"}, {"conceptId": "C93401", "definition": "A unique symbol that establishes identity of the organization. (BRIDG)", "preferredTerm": "Organization Identifier", "submissionValue": "Organization Identifier"}, {"conceptId": "C93874", "definition": "A non-unique textual identifier for the organization. (BRIDG)", "preferredTerm": "Organization Name", "submissionValue": "Organization Name"}, {"conceptId": "C188820", "definition": "A characterization or classification of the formalized group of persons or other organizations collected together for a common purpose (such as administrative, legal, political) and the infrastructure to carry out that purpose.", "preferredTerm": "Organization Type", "submissionValue": "Organization Type"}]}, {"conceptId": "C188716", "definition": "A terminology value set relevant to the attributes of the procedure.", "name": "DDF Procedure Attribute Terminology", "preferredTerm": "CDISC DDF Procedure Attribute Terminology", "submissionValue": "DDF Procedure Attribute Terminology", "synonyms": ["DDF Procedure Attribute Terminology"], "terms": [{"conceptId": "C154626", "definition": "A symbol or combination of symbols which is assigned to medical procedure.", "preferredTerm": "Procedure Code", "submissionValue": "Procedure Code"}, {"conceptId": "C201324", "definition": "The textual representation of the procedure.", "preferredTerm": "Procedure Description", "submissionValue": "Procedure Description"}, {"conceptId": "C201325", "definition": "The literal identifier (i.e., distinctive designation) of the procedure.", "preferredTerm": "Procedure Name", "submissionValue": "Procedure Name"}, {"conceptId": "C188848", "definition": "A characterization or classification of the study procedure.", "preferredTerm": "Study Procedure Type", "submissionValue": "Procedure Type"}, {"conceptId": "C201327", "definition": "The explanation for why the study procedure is subject to or dependent upon something else.", "preferredTerm": "Study Procedure is Conditional Reason", "submissionValue": "Study Procedure is Conditional Reason"}, {"conceptId": "C201326", "definition": "An indication as to whether the study procedure is subject to or dependent upon something else.", "preferredTerm": "Study Procedure is Conditional Indicator", "submissionValue": "Study Procedure is Conditional"}, {"conceptId": "C201329", "definition": "The explanation for why the study procedure is available to be performed but is not obligatory.", "preferredTerm": "Study Procedure is Optional Reason", "submissionValue": "Study Procedure is Optional Reason"}, {"conceptId": "C201328", "definition": "An indication as to whether the study procedure is available to be performed but is not obligatory.", "preferredTerm": "Study Procedure is Optional Indicator", "submissionValue": "Study Procedure is Optional"}]}, {"conceptId": "C201258", "definition": "A terminology value set relevant to the attributes of the response code.", "name": "DDF Response Code Attribute Terminology", "preferredTerm": "CDISC DDF Response Code Attribute Terminology", "submissionValue": "DDF Response Code Attribute Terminology", "synonyms": ["DDF Response Code Attribute Terminology"], "terms": [{"conceptId": "C25162", "definition": "A symbol or combination of symbols which is assigned to the members of a collection.", "preferredTerm": "Code", "submissionValue": "Code"}, {"conceptId": "C201330", "definition": "An indication as to whether the response code is activated for use within a given usage context.", "preferredTerm": "Response Code Enabled Indicator", "submissionValue": "Response Code Enabled Indicator"}]}, {"conceptId": "C201259", "definition": "A terminology value set relevant to the attributes of the schedule timeline.", "name": "DDF Schedule Timeline Attribute Terminology", "preferredTerm": "CDISC DDF Schedule Timeline Attribute Terminology", "submissionValue": "DDF Schedule Timeline Attribute Terminology", "synonyms": ["DDF Schedule Timeline Attribute Terminology"], "terms": [{"conceptId": "C201331", "definition": "An indication as to whether the timeline or timeline component is part of the central or principal timeline.", "preferredTerm": "Main Timeline Indicator", "submissionValue": "Main Timeline Indicator"}, {"conceptId": "C201332", "definition": "The textual representation of the schedule timeline.", "preferredTerm": "Schedule Timeline Description", "submissionValue": "Schedule Timeline Description"}, {"conceptId": "C201333", "definition": "A logical evaluation on which rests the validity of entry into a schedule timeline.", "preferredTerm": "Schedule Timeline Entry Condition", "submissionValue": "Schedule Timeline Entry Condition"}, {"conceptId": "C201334", "definition": "The literal identifier (i.e., distinctive designation) of the schedule timeline.", "preferredTerm": "Schedule Timeline Name", "submissionValue": "Schedule Timeline Name"}]}, {"conceptId": "C201260", "definition": "A terminology value set relevant to the attributes of the scheduled decision instance.", "name": "DDF Scheduled Decision Instance Attribute Terminology", "preferredTerm": "CDISC DDF Scheduled Decision Instance Attribute Terminology", "submissionValue": "DDF Scheduled Decision Instance Attribute Terminology", "synonyms": ["DDF Scheduled Decision Instance Attribute Terminology"], "terms": [{"conceptId": "C201335", "definition": "An allotting or appointment to a set of conditions that are to be met in order to make a logical decision.", "preferredTerm": "Condition Assignments", "submissionValue": "Condition Assignments"}]}, {"conceptId": "C201261", "definition": "A terminology value set relevant to the attributes of the scheduled instance.", "name": "DDF Scheduled Instance Attribute Terminology", "preferredTerm": "CDISC DDF Scheduled Instance Attribute Terminology", "submissionValue": "DDF Scheduled Instance Attribute Terminology", "synonyms": ["DDF Scheduled Instance Attribute Terminology"], "terms": [{"conceptId": "C201336", "definition": "A numeral or string of numerals expressing a relative sequence of scheduled temporal events.", "preferredTerm": "Schedule Sequence Number", "submissionValue": "Schedule Sequence Number"}, {"conceptId": "C201337", "definition": "A characterization or classification of the scheduled instance.", "preferredTerm": "Scheduled Instance Type", "submissionValue": "Scheduled Instance Type"}]}, {"conceptId": "C188709", "definition": "A terminology value set relevant to the attributes of the study Arm.", "name": "DDF Study Arm Attribute Terminology", "preferredTerm": "CDISC DDF Study Arm Attribute Terminology", "submissionValue": "DDF Study Arm Attribute Terminology", "synonyms": ["DDF Study Arm Attribute Terminology"], "terms": [{"conceptId": "C188828", "definition": "The textual representation of the study arm data origin.", "preferredTerm": "Study Arm Data Origin Description", "submissionValue": "Study Arm Data Origin Description"}, {"conceptId": "C188829", "definition": "A characterization or classification of the study arm with respect to where the study arm data originates.", "preferredTerm": "Study Arm Data Origin Type", "submissionValue": "Study Arm Data Origin Type"}, {"conceptId": "C93728", "definition": "The textual representation of the arm for the study.", "preferredTerm": "Arm Description", "submissionValue": "Study Arm Description", "synonyms": ["Arm Description"]}, {"conceptId": "C170984", "definition": "The literal identifier (i.e., distinctive designation) of the study arm.", "preferredTerm": "Planned Study Arm Name", "submissionValue": "Study Arm Name"}, {"conceptId": "C172457", "definition": "A characterization or classification of the study arm.", "preferredTerm": "Study Arm Type", "submissionValue": "Study Arm Type", "synonyms": ["Arm Type"]}]}, {"conceptId": "C188703", "definition": "A terminology value set relevant to the attributes of the study design.", "name": "DDF Study Design Attribute Terminology", "preferredTerm": "CDISC DDF Study Design Attribute Terminology", "submissionValue": "DDF Study Design Attribute Terminology", "synonyms": ["DDF Study Design Attribute Terminology"], "terms": [{"conceptId": "C98746", "definition": "The general design of the strategy for assigning interventions to participants in a clinical study. (clinicaltrials.gov)", "preferredTerm": "Intervention Model", "submissionValue": "Intervention Model Type", "synonyms": ["Intervention Model"]}, {"conceptId": "C147139", "definition": "Summary description of the overall study plan and design, should include treatments studied, population studied, level and method of blinding/unmasking, kind of controls, method of assignment to treatment, sequence and duration of study periods, any safety, data monitoring or special steering or evaluation committees, and interim analyses. (ICH E3)", "preferredTerm": "Study Design Description", "submissionValue": "Study Design Description", "synonyms": ["Overall Design", "Study Design Description", "Study Design Overview", "Summary of Study Design"]}, {"conceptId": "C201338", "definition": "The literal identifier (i.e., distinctive designation) of the study design.", "preferredTerm": "Study Design Name", "submissionValue": "Study Design Name"}, {"conceptId": "C142705", "definition": "Reason(s) for choosing the study design. This may include reasons for the choice of control or comparator, as well as the scientific rationale for the study design.", "preferredTerm": "Study Design Rationale", "submissionValue": "Study Design Rationale"}, {"conceptId": "C101302", "definition": "A categorization of a disease, disorder, or other condition based on common characteristics and often associated with a medical specialty focusing on research and development of specific therapeutic interventions for the purpose of treatment and prevention.", "preferredTerm": "Therapeutic Area", "submissionValue": "Therapeutic Areas", "synonyms": ["Therapeutic Area"]}, {"conceptId": "C49658", "definition": "The type of experimental design used to describe the level of awareness of the study subjects and/ or study personnel as it relates to the respective intervention(s) or assessments being observed, received or administered.", "preferredTerm": "Trial Blinding Schema", "submissionValue": "Trial Blinding Schema", "synonyms": ["Study Blinding Design", "Study Blinding Schema", "Study Masking Design", "Trial Blinding Design", "Trial Blinding Schema", "Trial Masking Design"]}, {"conceptId": "C49652", "definition": "The planned purpose of the therapy, device, or agent under study in the clinical trial.", "preferredTerm": "Clinical Study by Intent", "submissionValue": "Trial Intent Type", "synonyms": ["Trial Intent Type"]}, {"conceptId": "C49660", "definition": "The nature of the interventional study for which information is being collected.", "preferredTerm": "Trial Type", "submissionValue": "Trial Type", "synonyms": ["Trial Scope", "Trial Type"]}]}, {"conceptId": "C188706", "definition": "A terminology value set relevant to the attributes of the study design population.", "name": "DDF Study Design Population Attribute Terminology", "preferredTerm": "CDISC DDF Study Design Population Attribute Terminology", "submissionValue": "DDF Study Design Population Attribute Terminology", "synonyms": ["DDF Study Design Population Attribute Terminology"], "terms": [{"conceptId": "C49694", "definition": "The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)", "preferredTerm": "Planned Maximum Age of Subjects", "submissionValue": "Planned Maximum Age of Subjects", "synonyms": ["Planned Maximum Age of Subjects"]}, {"conceptId": "C49693", "definition": "The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)", "preferredTerm": "Planned Minimum Age of Subjects", "submissionValue": "Planned Minimum Age of Subjects", "synonyms": ["Planned Minimum Age of Subjects"]}, {"conceptId": "C49692", "definition": "The planned number of subjects to be entered in a clinical trial. (NCI)", "preferredTerm": "Planned Subject Number", "submissionValue": "Planned Number of Participants", "synonyms": ["Anticipated Enrollment", "Planned Enrollment", "Planned Number of Subjects", "Target Enrollment"]}, {"conceptId": "C49696", "definition": "The specific sex, either male, female, or mixed of the subject group being studied. (NCI)", "preferredTerm": "Sex of Study Group", "submissionValue": "Sex of Participants", "synonyms": ["Sex of Participants"]}, {"conceptId": "C70834", "definition": "The textual representation of the study population.", "preferredTerm": "Study Population Description", "submissionValue": "Target Study Population Description"}]}, {"conceptId": "C188711", "definition": "A terminology value set relevant to the attributes of the study element.", "name": "DDF Study Element Attribute Terminology", "preferredTerm": "CDISC DDF Study Element Attribute Terminology", "submissionValue": "DDF Study Element Attribute Terminology", "synonyms": ["DDF Study Element Attribute Terminology"], "terms": [{"conceptId": "C188834", "definition": "The textual representation of the study design element.", "preferredTerm": "Study Design Element Description", "submissionValue": "Study Design Element Description"}, {"conceptId": "C188833", "definition": "The literal identifier (i.e., distinctive designation) of the study design element.", "preferredTerm": "Study Design Element Name", "submissionValue": "Study Design Element Name"}, {"conceptId": "C201339", "definition": "A criterion that establishes the end of a subject transition within a study workflow.", "preferredTerm": "Transition End Rule", "submissionValue": "Transition End Rule"}, {"conceptId": "C201340", "definition": "A criterion that establishes the beginning of a subject transition within a study workflow.", "preferredTerm": "Transition Start Rule", "submissionValue": "Transition Start Rule"}]}, {"conceptId": "C188710", "definition": "A terminology value set relevant to the attributes of the study epoch.", "name": "DDF Study Epoch Attribute Terminology", "preferredTerm": "CDISC DDF Study Epoch Attribute Terminology", "submissionValue": "DDF Study Epoch Attribute Terminology", "synonyms": ["DDF Study Epoch Attribute Terminology"], "terms": [{"conceptId": "C188832", "definition": "A system identifier assigned to the epoch that occurs immediately after the current epoch.", "preferredTerm": "Next Epoch Identifier", "submissionValue": "Next Epoch Identifier"}, {"conceptId": "C188831", "definition": "A system identifier assigned to the epoch that occurs immediately prior to the current epoch.", "preferredTerm": "Previous Epoch Identifier", "submissionValue": "Previous Epoch Identifier"}, {"conceptId": "C93824", "definition": "The textual representation of the study epoch.", "preferredTerm": "Epoch Description", "submissionValue": "Study Epoch Description"}, {"conceptId": "C93825", "definition": "The literal identifier (i.e., distinctive designation) of the study epoch, i.e., the named time period defined in the protocol, wherein a study activity is specified and unchanging throughout the interval, to support a study-specific purpose.", "preferredTerm": "Epoch Name", "submissionValue": "Study Epoch Name"}, {"conceptId": "C188830", "definition": "A characterization or classification of the study epoch, i.e., the named time period defined in the protocol, wherein a study activity is specified and unchanging throughout the interval, to support a study-specific purpose.", "preferredTerm": "Study Epoch Type", "submissionValue": "Study Epoch Type"}]}, {"conceptId": "C188701", "definition": "A terminology value set relevant to the attributes of the study identifier.", "name": "DDF Study Identifier Attribute Terminology", "preferredTerm": "CDISC DDF Study Identifier Attribute Terminology", "submissionValue": "DDF Study Identifier Attribute Terminology", "synonyms": ["DDF Study Identifier Attribute Terminology"], "terms": [{"conceptId": "C83082", "definition": "A sequence of characters used to identify, name, or characterize the study.", "preferredTerm": "Study Identifier", "submissionValue": "Study Identifier"}]}, {"conceptId": "C188700", "definition": "A terminology value set relevant to the attributes of the study protocol version.", "name": "DDF Study Protocol Version Attribute Terminology", "preferredTerm": "CDISC DDF Study Protocol Version Attribute Terminology", "submissionValue": "DDF Study Protocol Version Attribute Terminology", "synonyms": ["DDF Study Protocol Version Attribute Terminology"], "terms": [{"conceptId": "C132345", "definition": "The short descriptive name for the protocol.", "preferredTerm": "Brief Protocol Title", "submissionValue": "Brief Protocol Title", "synonyms": ["Abbreviated Protocol Title"]}, {"conceptId": "C132346", "definition": "The formal descriptive name for the protocol.", "preferredTerm": "Official Protocol Title", "submissionValue": "Official Protocol Title"}, {"conceptId": "C188818", "definition": "A condition of the protocol at a point in time with respect to its state of readiness for implementation.", "preferredTerm": "Study Protocol Status", "submissionValue": "Protocol Status"}, {"conceptId": "C94105", "definition": "The descriptive name of the protocol that is intended for the lay public, written in easily understood language.", "preferredTerm": "Study Protocol Document Version Public Title", "submissionValue": "Public Protocol Title"}, {"conceptId": "C132350", "definition": "A more extensive descriptive name of the protocol that is intended for medical professionals, written using medical and scientific language.", "preferredTerm": "Scientific Protocol Title", "submissionValue": "Scientific Protocol Title"}, {"conceptId": "C188817", "definition": "The date and time specifying when the protocol amendment takes effect or becomes operative.", "preferredTerm": "Study Protocol Amendment Effective Date", "submissionValue": "Study Protocol Amendment Effective Date"}, {"conceptId": "C132347", "definition": "A written description of a change(s) to, or formal clarification of, a protocol. (ICH E6)", "preferredTerm": "Protocol Amendment", "submissionValue": "Study Protocol Amendment"}, {"conceptId": "C93490", "definition": "A plan at a particular point in time for a formal investigation to assess the utility, impact, pharmacological, physiological, and/or psychological effects of a particular treatment, procedure, drug, device, biologic, food product, cosmetic, care plan, or subject characteristic. (BRIDG)", "preferredTerm": "Study Protocol Version", "submissionValue": "Study Protocol Version"}]}, {"conceptId": "C201262", "definition": "A terminology value set relevant to the attributes of the timing.", "name": "DDF Timing Attribute Terminology", "preferredTerm": "CDISC DDF Timing Attribute Terminology", "submissionValue": "DDF Timing Attribute Terminology", "synonyms": ["DDF Timing Attribute Terminology"], "terms": [{"conceptId": "C164648", "definition": "The textual representation of the chronological relationship between temporal events.", "preferredTerm": "Timing Description", "submissionValue": "Timing Description"}, {"conceptId": "C201297", "definition": "The name of the reference event used to define the temporal relationship with another event.", "preferredTerm": "Timing Relative To From Name", "submissionValue": "Timing Relative To From"}, {"conceptId": "C201298", "definition": "A characterization or classification of the chronological relationship between temporal events.", "preferredTerm": "Timing Type", "submissionValue": "Timing Type"}, {"conceptId": "C201341", "definition": "The temporal value of the chronological relationship between temporal events.", "preferredTerm": "Timing Value", "submissionValue": "Timing Value"}, {"conceptId": "C48921", "definition": "A time period, or other type of interval, during which a temporal event may be achieved, obtained, or observed.", "preferredTerm": "Window", "submissionValue": "Timing Window"}, {"conceptId": "C201342", "definition": "The earliest chronological value of an allowable period of time during which a temporal event takes place.", "preferredTerm": "Lower Timing Window", "submissionValue": "Timing Window, Lower"}, {"conceptId": "C201343", "definition": "The latest chronological value of an allowable period of time during which a temporal event takes place.", "preferredTerm": "Upper Timing Window", "submissionValue": "Timing Window, Upper"}]}, {"conceptId": "C188712", "definition": "A terminology value set relevant to the attributes of the transition rule.", "name": "DDF Transition Rule Attribute Terminology", "preferredTerm": "CDISC DDF Transition Rule Attribute Terminology", "submissionValue": "DDF Transition Rule Attribute Terminology", "synonyms": ["DDF Transition Rule Attribute Terminology"], "terms": [{"conceptId": "C188835", "definition": "The textual representation of the transition rule.", "preferredTerm": "Transition Rule Description", "submissionValue": "Transition Rule Description"}]}, {"conceptId": "C188728", "definition": "The terminology relevant to the encounter type.", "name": "Encounter Type Value Set Terminology", "preferredTerm": "CDISC DDF Encounter Type Value Set Terminology", "submissionValue": "Encounter Type Value Set Terminology", "synonyms": ["Encounter Type Value Set Terminology"], "terms": [{"conceptId": "C25716", "definition": "The act of going to see some person or place or thing; it can cover a short or long period but refers to a non-permanent arrangement.", "preferredTerm": "Visit", "submissionValue": "Visit"}]}, {"conceptId": "C188726", "definition": "The terminology relevant to the endpoint level.", "name": "Endpoint Level Value Set Terminology", "preferredTerm": "CDISC DDF Endpoint Level Value Set Terminology", "submissionValue": "Endpoint Level Value Set Terminology", "synonyms": ["Endpoint Level Value Set Terminology"], "terms": [{"conceptId": "C170559", "definition": "Endpoint(s) that may include clinically important events that are expected to occur too infrequently to show a treatment effect or endpoints that for other reasons are thought to be less likely to show an effect but are included to explore new hypotheses. (After FDA-NIH Protocol Template)", "preferredTerm": "Exploratory Endpoint", "submissionValue": "Exploratory Endpoint"}, {"conceptId": "C94496", "definition": "Endpoint(s) of greatest importance that is the basis for concluding whether the study met its objective(s) and provides a clinically relevant, valid, and reliable measure of the primary objective(s). (After FDA-NIH Protocol Template)", "preferredTerm": "Primary Endpoint", "submissionValue": "Primary Endpoint"}, {"conceptId": "C139173", "definition": "Endpoint(s) that may provide supportive information about the effect of the study intervention(s) on the primary endpoint or demonstrate additional effects on the disease or condition. (After FDA-NIH Protocol Template)", "preferredTerm": "Secondary Endpoint", "submissionValue": "Secondary Endpoint"}]}, {"conceptId": "C127262", "definition": "Terminology relevant to the surroundings or environment.", "extensible": "true", "name": "Environmental Setting", "preferredTerm": "CDISC SDTM Environmental Setting Terminology", "submissionValue": "SETTING", "synonyms": ["Environmental Setting"], "terms": [{"conceptId": "C127785", "definition": "An establishment that provides care for infants and children.", "preferredTerm": "Childcare Center", "submissionValue": "CHILD CARE CENTER"}, {"conceptId": "C51282", "definition": "A health care facility where subjects or patients may receive assessments, procedures, or treatments that are provided by physicians and other healthcare providers.", "preferredTerm": "Clinic", "submissionValue": "CLINIC"}, {"conceptId": "C48953", "definition": "A tract of land cultivated for the purpose of agricultural production or devoted to the raising and breeding of domestic animals.", "preferredTerm": "Farm", "submissionValue": "FARM"}, {"conceptId": "C102650", "definition": "A setting outside the clinic or a comparable health care facility, e.g. a doctor's office, the subject's home or workplace, a school, a public park, or a restaurant.", "preferredTerm": "In the Field", "submissionValue": "FIELD"}, {"conceptId": "C21541", "definition": "The buildings and organizations where healthcare services are provided.", "preferredTerm": "Healthcare Facility", "submissionValue": "HEALTH FACILITY"}, {"conceptId": "C18002", "definition": "A person's place of residence.", "preferredTerm": "Home", "submissionValue": "HOME"}, {"conceptId": "C16696", "definition": "An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured.", "preferredTerm": "Hospital", "submissionValue": "HOSPITAL"}, {"conceptId": "C102647", "definition": "The area in which an individual lives.", "preferredTerm": "Household Environment", "submissionValue": "HOUSEHOLD ENVIRONMENT"}, {"conceptId": "C41206", "definition": "An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization.", "preferredTerm": "Institution", "submissionValue": "INSTITUTION"}, {"conceptId": "C181529", "definition": "A motorized conveyance for people and goods.", "preferredTerm": "Motor Vehicle", "submissionValue": "MOTOR VEHICLE"}, {"conceptId": "C102679", "definition": "An area outside of that in which an individual lives.", "preferredTerm": "Non-household Environment", "submissionValue": "NON-HOUSEHOLD ENVIRONMENT"}, {"conceptId": "C181530", "definition": "Any environmental setting outside of a clinic.", "preferredTerm": "Not In Clinic", "submissionValue": "NOT IN CLINIC"}, {"conceptId": "C16281", "definition": "A medical care center that provides healthcare services on an outpatient basis.", "preferredTerm": "Ambulatory Care Facility", "submissionValue": "OUTPATIENT CLINIC"}, {"conceptId": "C85862", "definition": "An institution where persons are confined for punishment and to protect the public.", "preferredTerm": "Correctional Institution", "submissionValue": "PRISON"}, {"conceptId": "C17118", "definition": "An educational institution.", "preferredTerm": "School", "submissionValue": "SCHOOL"}, {"conceptId": "C85863", "definition": "Temporary housing for displaced or at-risk persons.", "preferredTerm": "Shelter", "submissionValue": "SHELTER"}, {"conceptId": "C102712", "definition": "The surroundings or environment in which social activities occur.", "preferredTerm": "Social Setting", "submissionValue": "SOCIAL SETTING"}, {"conceptId": "C17556", "definition": "Place or physical location of work or employment.", "preferredTerm": "Worksite", "submissionValue": "WORKSITE"}]}, {"conceptId": "C99079", "definition": "The name of the EPOCH.", "extensible": "true", "name": "Epoch", "preferredTerm": "CDISC SDTM Epoch Terminology", "submissionValue": "EPOCH", "synonyms": ["Epoch"], "terms": [{"conceptId": "C125938", "definition": "A period in a clinical study after eligibility has been met and before the start of treatment, at which baseline measurements are collected.", "preferredTerm": "Baseline Epoch", "submissionValue": "BASELINE"}, {"conceptId": "C102255", "definition": "A period in a clinical study during which subjects receive blinded therapeutic treatment.", "preferredTerm": "Blinded Treatment Epoch", "submissionValue": "BLINDED TREATMENT"}, {"conceptId": "C123452", "definition": "A period in a clinical study during which subjects receive continuation treatment.", "preferredTerm": "Continuation Therapy Epoch", "submissionValue": "CONTINUATION TREATMENT", "synonyms": ["Continuation Phase"]}, {"conceptId": "C202578", "definition": "A period in a clinical study during which information about the health status of an individual is obtained after study interventions have concluded.", "preferredTerm": "Follow-Up Epoch", "submissionValue": "FOLLOW-UP"}, {"conceptId": "C123453", "definition": "A period in a clinical study during which subjects receive induction treatment.", "preferredTerm": "Induction Therapy Epoch", "submissionValue": "INDUCTION TREATMENT", "synonyms": ["Induction Phase", "Intensive Phase"]}, {"conceptId": "C202577", "definition": "A period in a clinical study during which information about the health status of an individual is obtained long after study interventions have concluded.", "preferredTerm": "Long-term Follow-up Epoch", "submissionValue": "LONG-TERM FOLLOW-UP"}, {"conceptId": "C165873", "definition": "A period in a clinical study during which subjects are observed, without any planned intervention.", "preferredTerm": "Observation Study Epoch", "submissionValue": "OBSERVATION"}, {"conceptId": "C102256", "definition": "A period in a clinical study during which subjects receive open label therapeutic treatment.", "preferredTerm": "Open Label Treatment Epoch", "submissionValue": "OPEN LABEL TREATMENT"}, {"conceptId": "C199844", "definition": "A period in a clinical study during which subjects are evaluated prior to entering the full screening period.", "preferredTerm": "Pre-Screening Epoch", "submissionValue": "PRE-SCREENING"}, {"conceptId": "C98779", "definition": "A period in a clinical study that occurs after screening and before randomization, during which the subject is further evaluated and/or prepared for the commencement of the clinical study investigation.", "preferredTerm": "Run-in Period", "submissionValue": "RUN-IN"}, {"conceptId": "C202487", "definition": "A period in a clinical study during which subjects are evaluated for participation in the study.", "preferredTerm": "Screening Epoch", "submissionValue": "SCREENING"}, {"conceptId": "C101526", "definition": "A period in a study during which subjects are receiving investigational therapy or treatment.", "preferredTerm": "Treatment Epoch", "submissionValue": "TREATMENT"}, {"conceptId": "C42872", "definition": "A period of time during a study when a subject is taken off of the investigational therapy or treatment in order to reduce the amount of investigational product within the body.", "preferredTerm": "Washout Period", "submissionValue": "WASHOUT"}]}, {"conceptId": "C99076", "definition": "A terminology codelist relevant to the trial design developed to compare treatment groups.", "extensible": "true", "name": "Intervention Model Response", "preferredTerm": "CDISC SDTM Intervention Model Terminology", "submissionValue": "INTMODEL", "synonyms": ["Intervention Model Response"], "terms": [{"conceptId": "C82637", "definition": "Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the study.", "preferredTerm": "Crossover Study", "submissionValue": "CROSS-OVER"}, {"conceptId": "C82638", "definition": "Two or more interventions, each alone or in combination, are evaluated in parallel against a control group. This study design allows for the comparison of active drug to placebo, presence of drug-drug interactions, and comparison of active drugs against each other.", "preferredTerm": "Factorial Study", "submissionValue": "FACTORIAL"}, {"conceptId": "C82639", "definition": "Participants are assigned to one of two or more treatment groups in parallel for the duration of the study.", "preferredTerm": "Parallel Study", "submissionValue": "PARALLEL"}, {"conceptId": "C142568", "definition": "Groups of participants are assigned to receive interventions based on prior milestones being reached in the study. (clinicaltrials.gov)", "preferredTerm": "Group Sequential Design", "submissionValue": "SEQUENTIAL"}, {"conceptId": "C82640", "definition": "All trial participants are assigned to a single treatment group for the duration of the study.", "preferredTerm": "Single Group Study", "submissionValue": "SINGLE GROUP"}]}, {"conceptId": "C171445", "definition": "Terminology relevant to the means by which interaction occurs between the subject and person or entity.", "extensible": "true", "name": "Mode of Subject Contact", "preferredTerm": "CDISC SDTM Mode of Subject Contact Terminology", "submissionValue": "CNTMODE", "synonyms": ["Mode of Subject Contact"], "terms": [{"conceptId": "C25170", "definition": "Composing, sending, and receiving messages over electronic communication systems.", "preferredTerm": "E-mail", "submissionValue": "E-MAIL", "synonyms": ["Electronic Mail"]}, {"conceptId": "C175574", "definition": "An interaction that takes place in the physical presence of someone else.", "preferredTerm": "In Person", "submissionValue": "IN PERSON", "synonyms": ["In-Person"]}, {"conceptId": "C177933", "definition": "A type of automated system in which individuals can access information menus containing pre-recorded or dynamically generated information with voice prompts, without the need for an agent or operator.", "preferredTerm": "Interactive Voice Response System", "submissionValue": "IVRS", "synonyms": ["Interactive Voice Response System"]}, {"conceptId": "C70805", "definition": "A written message addressed to a person or organization.", "preferredTerm": "Letter", "submissionValue": "LETTER"}, {"conceptId": "C171525", "definition": "A form of remote communication by audio video technology.", "preferredTerm": "Audio-Videoconferencing", "submissionValue": "REMOTE AUDIO VIDEO"}, {"conceptId": "C171524", "definition": "A form of remote communication by audio technology.", "preferredTerm": "Audioconferencing", "submissionValue": "REMOTE AUDIO"}, {"conceptId": "C171533", "definition": "Receipt of shipped material was confirmed by signature.", "preferredTerm": "Shipment Confirmed by Signature", "submissionValue": "SHIPMENT CONFIRMED BY SIGNATURE"}, {"conceptId": "C171537", "definition": "Communication by way of telephone.", "preferredTerm": "Telephone Call", "submissionValue": "TELEPHONE CALL"}, {"conceptId": "C157352", "definition": "A short electronic communication, usually sent and received by a mobile phone.", "preferredTerm": "Text Message", "submissionValue": "TEXT MESSAGE"}]}, {"conceptId": "C188725", "definition": "The terminology relevant to the objective level.", "name": "Objective Level Value Set Terminology", "preferredTerm": "CDISC DDF Objective Level Value Set Terminology", "submissionValue": "Objective Level Value Set Terminology", "synonyms": ["Objective Level Value Set Terminology"], "terms": [{"conceptId": "C85826", "definition": "A principle objective of the study.", "preferredTerm": "Trial Primary Objective", "submissionValue": "Study Primary Objective", "synonyms": ["Study Primary Objective", "Trial Primary Objective"]}, {"conceptId": "C85827", "definition": "An auxiliary objective of the study.", "preferredTerm": "Trial Secondary Objective", "submissionValue": "Study Secondary Objective", "synonyms": ["Study Secondary Objective", "Trial Secondary Objective"]}]}, {"conceptId": "C188724", "definition": "The terminology relevant to the organization type.", "name": "Organization Type Value Set Terminology", "preferredTerm": "CDISC DDF Organization Type Value Set Terminology", "submissionValue": "Organization Type Value Set Terminology", "synonyms": ["Organization Type Value Set Terminology"], "terms": [{"conceptId": "C93453", "definition": "An organization (typically a government agency) that administers the registration of studies. (BRIDG)", "preferredTerm": "Study Registry", "submissionValue": "Clinical Study Registry"}, {"conceptId": "C70793", "definition": "An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP]", "preferredTerm": "Clinical Study Sponsor", "submissionValue": "Clinical Study Sponsor", "synonyms": ["Clinical Study Sponsor", "Sponsor", "Study Sponsor"]}, {"conceptId": "C188863", "definition": "An organization (typically a government agency) that is responsible for implementing and enforcing laws, licensing and regulating products and services, promoting the use of standards, and ensuring safety and consumer protections.", "preferredTerm": "Regulatory Agency", "submissionValue": "Regulatory Agency", "synonyms": ["Regulator", "Regulatory Body"]}]}, {"conceptId": "C188723", "definition": "The terminology relevant to the protocol status.", "name": "Protocol Status Value Set Terminology", "preferredTerm": "CDISC DDF Protocol Status Value Set Terminology", "submissionValue": "Protocol Status Value Set Terminology", "synonyms": ["Protocol Status Value Set Terminology"], "terms": [{"conceptId": "C25425", "definition": "Acceptance as satisfactory by an authoritative body; established by authority; given authoritative approval.", "preferredTerm": "Approval", "submissionValue": "Approved"}, {"conceptId": "C85255", "definition": "A preliminary version of a written work, design, or picture.", "preferredTerm": "Draft", "submissionValue": "Draft"}, {"conceptId": "C25508", "definition": "Conclusive in a process or progression.", "preferredTerm": "Final", "submissionValue": "Final"}, {"conceptId": "C63553", "definition": "No longer in use or valid; old.", "preferredTerm": "Obsolete", "submissionValue": "Obsolete"}, {"conceptId": "C188862", "definition": "A preliminary version of a written work, design, or picture that is awaiting review.", "preferredTerm": "Pending Review", "submissionValue": "Pending Review", "synonyms": ["Draft Pending Review"]}]}, {"conceptId": "C66732", "definition": "A terminology codelist relevant to the specific sex, either male, female, or mixed of the subject group being studied.", "extensible": "false", "name": "Sex of Participants Response", "preferredTerm": "CDISC SDTM Sex of Study Group Terminology", "submissionValue": "SEXPOP", "synonyms": ["Sex of Participants Response"], "terms": [{"conceptId": "C49636", "definition": "One and the other; relating to or being two in conjunction. (NCI)", "preferredTerm": "Both", "submissionValue": "BOTH"}, {"conceptId": "C16576", "definition": "A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)", "preferredTerm": "Female", "submissionValue": "F", "synonyms": ["Female"]}, {"conceptId": "C20197", "definition": "A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)", "preferredTerm": "Male", "submissionValue": "M", "synonyms": ["Male"]}]}, {"conceptId": "C188727", "definition": "The terminology relevant to the study arm data origin type.", "name": "Study Arm Data Origin Type Value Set Terminology", "preferredTerm": "CDISC DDF Study Arm Data Origin Type Value Set Terminology", "submissionValue": "Study Arm Data Origin Type Value Set Terminology", "synonyms": ["Study Arm Data Origin Type Value Set Terminology"], "terms": [{"conceptId": "C188866", "definition": "Data that are generated from the current study.", "preferredTerm": "Data Generated Within Study", "submissionValue": "Data Generated Within Study"}, {"conceptId": "C188864", "definition": "Data from studies that have occurred in the past.", "preferredTerm": "Historical Data", "submissionValue": "Historical Data"}, {"conceptId": "C165830", "definition": "Data relating to patient health status and/or the delivery of health care routinely collected from sources other than traditional clinical trials. NOTE: Examples of sources include data derived from electronic health records (EHRs); medical claims and billing data; data from product and disease registries; patient-generated data, including from in-home-use settings; and data gathered from other sources that can inform on health status, such as mobile devices. [After 21 U.S.C. 355g(b)).5 and Framework for FDA's Real-World Evidence Program December 2018] See also Real-World Evidence (RWE)", "preferredTerm": "Real-world Data", "submissionValue": "Real World Data"}, {"conceptId": "C176263", "definition": "Data that are artificially created rather than being generated by actual events. NOTE: Data are often created with the help of algorithms and used for a wide range of activities, including as test data for new products and tools, for model validation, and in AI optimization. [After The Ultimate Guide to Synthetic Data in 2020, August 29, 2020]. See also artificial intelligence.", "preferredTerm": "Synthetic Data", "submissionValue": "Synthetic Data"}, {"conceptId": "C188865", "definition": "Data that are generated from virtual encounters between investigators and subjects.", "preferredTerm": "Virtual Data", "submissionValue": "Virtual Data"}]}, {"conceptId": "C174222", "definition": "The terminology relevant to the identification of the kind of arm.", "name": "Study Arm Type Value Set Terminology", "preferredTerm": "CDISC Protocol Study Arm Type Value Set Terminology", "submissionValue": "Study Arm Type Value Set Terminology", "synonyms": ["Study Arm Type Value Set Terminology"], "terms": [{"conceptId": "C174267", "definition": "An arm describing the active comparator.", "preferredTerm": "Active Comparator Arm", "submissionValue": "Active Comparator Arm"}, {"conceptId": "C174226", "definition": "An arm describing the intervention or treatment plan for a group of participants in the study receiving a control. The control may comprise a non-investigational product (active control) or regimen, placebo, or no treatment.", "preferredTerm": "Control Arm", "submissionValue": "Control Arm"}, {"conceptId": "C174266", "definition": "An arm describing the intervention or treatment plan for a group of participants in the study receiving test product(s).", "preferredTerm": "Investigational Arm", "submissionValue": "Experimental Arm", "synonyms": ["Investigational Arm"]}, {"conceptId": "C174270", "definition": "A study arm without an intervention or treatment.", "preferredTerm": "No Intervention Arm", "submissionValue": "No Intervention Arm"}, {"conceptId": "C174268", "definition": "An arm describing the placebo comparator.", "preferredTerm": "Placebo Control Arm", "submissionValue": "Placebo Comparator Arm", "synonyms": ["Placebo Control Arm"]}, {"conceptId": "C174269", "definition": "An arm describing the sham comparator.", "preferredTerm": "Sham Comparator Arm", "submissionValue": "Sham Comparator Arm", "synonyms": ["Sham Intervention Arm"]}, {"conceptId": "C15538", "definition": "An arm describing the intervention or treatment plan for a group of participants in the study. Treatment may consist of either experimental or control products under investigation.", "preferredTerm": "Protocol Treatment Arm", "submissionValue": "Treatment Arm"}]}, {"conceptId": "C99077", "definition": "A terminology codelist relevant to the role the study plays in determining the interventions a subject receives.", "extensible": "false", "name": "Study Type Response", "preferredTerm": "CDISC SDTM Study Type Terminology", "submissionValue": "STYPE", "synonyms": ["Study Type Response"], "terms": [{"conceptId": "C98722", "definition": "Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in another clinical study.", "preferredTerm": "Expanded Access Study", "submissionValue": "EXPANDED ACCESS", "synonyms": ["Compassionate Use"]}, {"conceptId": "C98388", "definition": "Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. The individuals are then followed and biomedical and/or health outcomes are assessed.", "preferredTerm": "Interventional Study", "submissionValue": "INTERVENTIONAL"}, {"conceptId": "C16084", "definition": "Studies in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study.", "preferredTerm": "Observational Study", "submissionValue": "OBSERVATIONAL"}, {"conceptId": "C129000", "definition": "Observational studies which include an organized system that uses observational methods to collect uniform data (clinical and other) prospectively for a population defined by a particular disorder/disease, condition (including susceptibility to a disorder), or exposure (including products, health care services, and/or procedures) and that serves a predetermined scientific, clinical, or policy purpose. Patient registries may be single purpose or on-going data collection programs that address one or more questions. (AHRQ)", "preferredTerm": "Patient Registry Study", "submissionValue": "PATIENT REGISTRY"}]}, {"conceptId": "C201265", "definition": "The terminology relevant to the timing relative to from value set.", "name": "Timing Relative To From Value Set Terminology", "preferredTerm": "CDISC DDF Timing Relative To From Value Set Terminology", "submissionValue": "Timing Relative To From Value Set Terminology", "synonyms": ["Timing Relative To From Value Set Terminology"], "terms": [{"conceptId": "C201352", "definition": "A timing relationship defined as the end of one event to the end of another event.", "preferredTerm": "End to End", "submissionValue": "End to End"}, {"conceptId": "C201353", "definition": "A timing relationship defined as the end of one event to the start of another event.", "preferredTerm": "End to Start", "submissionValue": "End to Start"}, {"conceptId": "C201354", "definition": "A timing relationship defined as the start of one event to the end of another event.", "preferredTerm": "Start to End", "submissionValue": "Start to End"}, {"conceptId": "C201355", "definition": "A timing relationship defined as the start of one event to the start of another event.", "preferredTerm": "Start to Start", "submissionValue": "Start to Start"}]}, {"conceptId": "C201264", "definition": "The terminology relevant to the timing type value set.", "name": "Timing Type Value Set Terminology", "preferredTerm": "CDISC DDF Timing Type Value Set Terminology", "submissionValue": "Timing Type Value Set Terminology", "synonyms": ["Timing Type Value Set Terminology"], "terms": [{"conceptId": "C201356", "definition": "A type of time point relationship that follows a point or period of time within a timeline.", "preferredTerm": "After Timing Type", "submissionValue": "After"}, {"conceptId": "C201357", "definition": "A type of time point relationship that comes before a point or period of time within a timeline.", "preferredTerm": "Before Timing Type", "submissionValue": "Before"}, {"conceptId": "C201358", "definition": "A type of time point relationship that is fixed with respect to a timeline.", "preferredTerm": "Fixed Reference Timing Type", "submissionValue": "Fixed Reference"}]}, {"conceptId": "C66735", "definition": "A terminology codelist relevant to the type of blinding for the trial.", "extensible": "true", "name": "Trial Blinding Schema Response", "preferredTerm": "CDISC SDTM Trial Blinding Schema Terminology", "submissionValue": "TBLIND", "synonyms": ["Trial Blinding Schema Response"], "terms": [{"conceptId": "C15228", "definition": "A study in which neither the subject nor the study personnel interacting with the subject or data during the study knows what intervention a subject is receiving.", "preferredTerm": "Double Blind Study", "submissionValue": "DOUBLE BLIND", "synonyms": ["Double Masked", "Double-Masked"]}, {"conceptId": "C187674", "definition": "A study in which the study personnel who measure, record, or assess the subject do not know which intervention the subject is receiving or, in the context of observational studies, do not know the external factors to which a subject has been exposed.", "preferredTerm": "Observer Blind Study", "submissionValue": "OBSERVER BLIND"}, {"conceptId": "C156592", "definition": "A study in which the therapeutic treatment is open label but the dosing information of the investigational medicinal product (IMP) is double-blinded.", "preferredTerm": "Open Label for Treatment And Double Blind to Dose", "submissionValue": "OPEN LABEL TO TREATMENT AND DOUBLE BLIND TO IMP DOSE"}, {"conceptId": "C49659", "definition": "A study in which subjects and study personnel know which intervention each subject is receiving.", "preferredTerm": "Open Label Study", "submissionValue": "OPEN LABEL"}, {"conceptId": "C28233", "definition": "A study in which one party, either the subject or study personnel, does not know which intervention is administered to the subject.", "preferredTerm": "Single Blind Study", "submissionValue": "SINGLE BLIND", "synonyms": ["Single Masked", "Single-Masked"]}]}, {"conceptId": "C66736", "definition": "A terminology codelist relevant to the responses for the planned purpose of the therapy, device, or agent under study in the clinical trial.", "extensible": "true", "name": "Trial Intent Type Response", "preferredTerm": "CDISC SDTM Trial Indication Type Terminology", "submissionValue": "TINDTP", "synonyms": ["Trial Intent Type Response"], "terms": [{"conceptId": "C15714", "definition": "A type of study designed to examine the basic mechanism of action (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov)", "preferredTerm": "Basic Research", "submissionValue": "BASIC SCIENCE", "synonyms": ["Basic Research"]}, {"conceptId": "C49654", "definition": "A type of study designed to evaluate intervention(s) aimed to cure a disease or condition.", "preferredTerm": "Cure Study", "submissionValue": "CURE"}, {"conceptId": "C139174", "definition": "An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial. (ClinicalTrials.gov)", "preferredTerm": "Device Feasibility Study", "submissionValue": "DEVICE FEASIBILITY"}, {"conceptId": "C49653", "definition": "A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition.", "preferredTerm": "Diagnosis Study", "submissionValue": "DIAGNOSIS"}, {"conceptId": "C170629", "definition": "A type of study designed to evaluate the effects of treatment(s) intended to cause a change in disease, syndrome, or condition beyond the point of treatment administration.", "preferredTerm": "Disease Modifying Treatment Study", "submissionValue": "DISEASE MODIFYING"}, {"conceptId": "C15245", "definition": "A type of study designed to evaluate the delivery, processes, management, organization or financing of health care. (ClinicalTrials.gov)", "preferredTerm": "Health Services Research", "submissionValue": "HEALTH SERVICES RESEARCH"}, {"conceptId": "C49655", "definition": "A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen. (NCI)", "preferredTerm": "Adverse Effect Mitigation Study", "submissionValue": "MITIGATION"}, {"conceptId": "C49657", "definition": "A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.", "preferredTerm": "Prevention Study", "submissionValue": "PREVENTION", "synonyms": ["Prophylaxis Study"]}, {"conceptId": "C71485", "definition": "A type of study designed to assess or examine methods of identifying a condition (or risk factors for a condition) in people who are not yet known to have the condition (or risk factor). (Clinicaltrials.gov)", "preferredTerm": "Screening Study", "submissionValue": "SCREENING"}, {"conceptId": "C71486", "definition": "A type of study designed to evaluate one or more interventions where the primary intent is to maximize comfort, minimize side effects or mitigate against a decline in the subject's health or function. In general, supportive care interventions are not intended to cure a disease. (ClinicalTrials.gov)", "preferredTerm": "Supportive Care Study", "submissionValue": "SUPPORTIVE CARE"}, {"conceptId": "C49656", "definition": "A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition.", "preferredTerm": "Treatment Study", "submissionValue": "TREATMENT", "synonyms": ["Therapy Trial"]}]}, {"conceptId": "C66737", "definition": "A terminology codelist relevant to the phase, or stage, of the clinical trial.", "extensible": "true", "name": "Trial Phase Response", "preferredTerm": "CDISC SDTM Trial Phase Terminology", "submissionValue": "TPHASE", "synonyms": ["Trial Phase Response"], "terms": [{"conceptId": "C48660", "definition": "Determination of a value is not relevant in the current context. (NCI)", "preferredTerm": "Not Applicable", "submissionValue": "NOT APPLICABLE", "synonyms": ["NA", "Not Applicable"]}, {"conceptId": "C54721", "definition": "First-in-human trials, in a small number of subjects, that are conducted before Phase 1 trials and are intended to assess new candidate therapeutic and imaging agents. The study agent is administered at a low dose for a limited time, and there is no therapeutic or diagnostic intent. NOTE: FDA Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies, January 2006 classifies such studies as Phase 1. NOTE: A Phase 0 study might not include any drug delivery but may be an exploration of human material from a study (e.g., tissue samples or biomarker determinations). [Improving the Quality of Cancer Clinical Trials: Workshop summary-Proceedings of the National Cancer Policy Forum Workshop, improving the Quality of Cancer Clinical Trials (Washington, DC, Oct 2007)] (CDISC glossary)", "preferredTerm": "Phase 0 Trial", "submissionValue": "PHASE 0 TRIAL", "synonyms": ["0", "Pre-clinical Trial", "Trial Phase 0"]}, {"conceptId": "C15600", "definition": "The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary)", "preferredTerm": "Phase I Trial", "submissionValue": "PHASE I TRIAL", "synonyms": ["1", "Trial Phase 1"]}, {"conceptId": "C15693", "definition": "A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.", "preferredTerm": "Phase I/II Trial", "submissionValue": "PHASE I/II TRIAL", "synonyms": ["1-2", "Trial Phase 1-2"]}, {"conceptId": "C198366", "definition": "A study that begins as a Phase I study and transitions into Phases II and III based upon successful completion of each previous portion.", "preferredTerm": "Phase I/II/III Trial", "submissionValue": "PHASE I/II/III TRIAL", "synonyms": ["1/2/3", "Trial Phase 1/2/3"]}, {"conceptId": "C198367", "definition": "A study that begins as a Phase I study and transitions into a Phase III study upon successful completion of the Phase I portion.", "preferredTerm": "Phase I/III Trial", "submissionValue": "PHASE I/III TRIAL", "synonyms": ["1/3", "Trial Phase 1/3"]}, {"conceptId": "C199990", "definition": "A type of phase 1 trial with a single ascending dose (dose escalation) in a smaller group of patients (in comparison to a Phase 1B).", "preferredTerm": "Phase Ia Trial", "submissionValue": "PHASE IA TRIAL", "synonyms": ["1A", "Trial Phase 1A"]}, {"conceptId": "C199989", "definition": "A type of phase 1 trial with multiple ascending doses (dose expansion) in a larger group of patients (in comparison to a Phase 1A).", "preferredTerm": "Phase Ib Trial", "submissionValue": "PHASE IB TRIAL", "synonyms": ["1B", "Trial Phase 1B"]}, {"conceptId": "C15601", "definition": "Phase that includes the controlled clinical trials conducted to evaluate the safety and efficacy of the drug in a limited number of patients with the disease or condition under study. Objectives can be dose-ranging (dose-response, frequency of dosing), type of patients, or numerous other characteristics of safety and efficacy. [After 21 CRF Part 312.21 Phases of an investigation] See also phase, phase 2a, phase 2b. (CDISC Glossary)", "preferredTerm": "Phase II Trial", "submissionValue": "PHASE II TRIAL", "synonyms": ["2", "Trial Phase 2"]}, {"conceptId": "C15694", "definition": "A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.", "preferredTerm": "Phase II/III Trial", "submissionValue": "PHASE II/III TRIAL", "synonyms": ["2-3", "Trial Phase 2-3"]}, {"conceptId": "C49686", "definition": "Early Phase 2 trials that focus on a proof-of-concept assessment of efficacy and safety in a small number of patients. [After FDA Guidance for industry end of Phase 2a meetings, September 2009] (CDISC Glossary)", "preferredTerm": "Phase IIa Trial", "submissionValue": "PHASE IIA TRIAL", "synonyms": ["2A", "Trial Phase 2A"]}, {"conceptId": "C49688", "definition": "Later Phase 2 trials, in transition to Phase 3, where the study populations more closely reflect the population, dosage, and condition for intended use. [Clarification of FDA Guidance for industry end of Phase 2a meetings, September 2009; Discussion in Peter B. Gilbert. SOME DESIGN ISSUES IN PHASE 2B VERSUS PHASE 3 PREVENTION TRIALS FOR TESTING EFFICACY OF PRODUCTS OR CONCEPTS. Stat Med. 2010 May 10; 29(10): 1061-1071.]", "preferredTerm": "Phase IIb Trial", "submissionValue": "PHASE IIB TRIAL", "synonyms": ["2B", "Trial Phase 2B"]}, {"conceptId": "C15602", "definition": "Phase that includes the controlled clinical trials intended to confirm safety and effectiveness, evaluate the overall benefit-risk relationship, and to provide substantial evidence for regulatory approval and labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After ICH E8; Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Draft Guidance for Industry. December 2019] See also phase, phase 3b. (CDISC Glossary)", "preferredTerm": "Phase III Trial", "submissionValue": "PHASE III TRIAL", "synonyms": ["3", "Trial Phase 3"]}, {"conceptId": "C49687", "definition": "A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial. (NCI)", "preferredTerm": "Phase IIIa Trial", "submissionValue": "PHASE IIIA TRIAL", "synonyms": ["3A", "Trial Phase 3A"]}, {"conceptId": "C49689", "definition": "Later Phase 3 trial done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase 3b trials are conducted. These trials may be required as a condition of regulatory authority approval. Phase 3a is in common usage but not reflected in regulatory guidance. (CDISC Glossary)", "preferredTerm": "Phase IIIb Trial", "submissionValue": "PHASE IIIB TRIAL", "synonyms": ["3B", "Trial Phase 3B"]}, {"conceptId": "C15603", "definition": "Post-approval studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: Phase 4 studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [after FDA CDER handbook, ICH E8] See also phase. (CDISC Glossary)", "preferredTerm": "Phase IV Trial", "submissionValue": "PHASE IV TRIAL", "synonyms": ["4", "Trial Phase 4"]}, {"conceptId": "C47865", "definition": "Postmarketing surveillance is sometimes referred to as Phase V.", "preferredTerm": "Phase V Trial", "submissionValue": "PHASE V TRIAL", "synonyms": ["5", "Trial Phase 5"]}]}, {"conceptId": "C66739", "definition": "A terminology codelist relevant to the type of primary outcome or endpoint that the protocol is designed to evaluate.", "extensible": "true", "name": "Trial Type Response", "preferredTerm": "CDISC SDTM Trial Type Terminology", "submissionValue": "TTYPE", "synonyms": ["Trial Type Response"], "terms": [{"conceptId": "C158283", "definition": "A type of study designed to evaluate the strength of the bond between an adhesive and the application surface.", "preferredTerm": "Adhesion Performance Study", "submissionValue": "ADHESION PERFORMANCE"}, {"conceptId": "C158284", "definition": "A type of study designed to evaluate the effects of alcohol on investigational product safety and/or efficacy.", "preferredTerm": "Alcohol Effect Study", "submissionValue": "ALCOHOL EFFECT"}, {"conceptId": "C49664", "definition": "A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)", "preferredTerm": "Bioavailability Study", "submissionValue": "BIO-AVAILABILITY"}, {"conceptId": "C49665", "definition": "A study most often used to compare the efficacy of different formulations to treat a given disease. It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)", "preferredTerm": "Therapeutic Equivalency Study", "submissionValue": "BIO-EQUIVALENCE"}, {"conceptId": "C158288", "definition": "A type of study designed to evaluate whether a biologic test article is highly similar in function and effect to an existing biologic that has already been clinically tested and approved for use.", "preferredTerm": "Biosimilarity Study", "submissionValue": "BIOSIMILARITY"}, {"conceptId": "C158285", "definition": "A type of study designed to evaluate the interaction between a device and a drug, where the use of one may affect the disposition, function, efficacy, or safety of the other.", "preferredTerm": "Device-Drug Interaction Study", "submissionValue": "DEVICE-DRUG INTERACTION"}, {"conceptId": "C49653", "definition": "A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition.", "preferredTerm": "Diagnosis Study", "submissionValue": "DIAGNOSIS"}, {"conceptId": "C158289", "definition": "An early phase clinical study with the objective of determining the optimal dose of an investigational product.", "preferredTerm": "Dose Finding Study", "submissionValue": "DOSE FINDING"}, {"conceptId": "C158290", "definition": "A type of study designed to evaluate the relationship between dose and resulting exposure.", "preferredTerm": "Dose Proportionality Study", "submissionValue": "DOSE PROPORTIONALITY"}, {"conceptId": "C127803", "definition": "A study of the effect of dose changes on the efficacy of a drug in order to determine the dose-response relationship and optimal dose of a therapy.", "preferredTerm": "Dose Response Study", "submissionValue": "DOSE RESPONSE"}, {"conceptId": "C158286", "definition": "A type of study designed to evaluate the interaction between drugs, where the use of one may affect the disposition, efficacy, or safety of the other.", "preferredTerm": "Drug-Drug Interaction Study", "submissionValue": "DRUG-DRUG INTERACTION"}, {"conceptId": "C178057", "definition": "A study that evaluates the effect of a treatment on cardiac electrical activity, as assessed by electrocardiography.", "preferredTerm": "Electrocardiographic Study", "submissionValue": "ECG", "synonyms": ["Electrocardiographic Study"]}, {"conceptId": "C49666", "definition": "A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)", "preferredTerm": "Efficacy Study", "submissionValue": "EFFICACY"}, {"conceptId": "C98729", "definition": "Studies that are conducted to assess the effect of food on the rate and extent of absorption of a drug, either compared to a fasted state or to a reference drug.", "preferredTerm": "Food Effect Study", "submissionValue": "FOOD EFFECT"}, {"conceptId": "C120842", "definition": "A study that assesses an agent's ability to provoke an immune response.", "preferredTerm": "Immunogenicity Study", "submissionValue": "IMMUNOGENICITY"}, {"conceptId": "C201484", "definition": "A type of study designed to evaluate the overall pathways of metabolism and excretion of a drug, and to identify and/or quantify metabolites in plasma and excreta.", "preferredTerm": "Mass Balance Study", "submissionValue": "MASS BALANCE"}, {"conceptId": "C49662", "definition": "A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)", "preferredTerm": "Pharmacodynamic Study", "submissionValue": "PHARMACODYNAMIC"}, {"conceptId": "C39493", "definition": "A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)", "preferredTerm": "Pharmacoeconomic Study", "submissionValue": "PHARMACOECONOMIC"}, {"conceptId": "C129001", "definition": "A study that assesses variation in DNA sequence, usually within a single gene, and its effect on drug response.", "preferredTerm": "Pharmacogenetic Study", "submissionValue": "PHARMACOGENETIC"}, {"conceptId": "C49661", "definition": "A study that identifies or assesses variations within the entire genome, including DNA, RNA, or transcriptional elements, and its effects on drug response.", "preferredTerm": "Pharmacogenomic Study", "submissionValue": "PHARMACOGENOMIC"}, {"conceptId": "C49663", "definition": "A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)", "preferredTerm": "Pharmacokinetic Study", "submissionValue": "PHARMACOKINETIC"}, {"conceptId": "C161477", "definition": "A type of study designed to evaluate the effect of body position during and/or after administration of the investigational product.", "preferredTerm": "Position Effect Trial", "submissionValue": "POSITION EFFECT"}, {"conceptId": "C49657", "definition": "A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.", "preferredTerm": "Prevention Study", "submissionValue": "PREVENTION", "synonyms": ["Prophylaxis Study"]}, {"conceptId": "C174366", "definition": "A type of study designed to evaluate the expected, acute types of immunological responses, sometimes considered excessive, following agent administration.", "preferredTerm": "Reactogenicity Study", "submissionValue": "REACTOGENICITY"}, {"conceptId": "C49667", "definition": "A study that assesses the medical risks to a subject. Safety is usually assessed by examining a wide range of clinical parameters, including adverse events, vital signs, physical exam, laboratory tests.", "preferredTerm": "Safety Study", "submissionValue": "SAFETY"}, {"conceptId": "C161478", "definition": "A type of study designed to evaluate the effect of the investigational product on the physiologic act of swallowing.", "preferredTerm": "Swallowing Function Trial", "submissionValue": "SWALLOWING FUNCTION"}, {"conceptId": "C158287", "definition": "A type of study designed to evaluate the ability of an investigational product and/or approved drug to delay cardiac ventricular repolarization as detected by QT prolongation and other ECG parameters.", "preferredTerm": "Thorough QT Study", "submissionValue": "THOROUGH QT", "synonyms": ["TQT Study"]}, {"conceptId": "C98791", "definition": "A type of safety study that assesses the degree to which overt adverse effects can be tolerated by the subject.", "preferredTerm": "Tolerability Study", "submissionValue": "TOLERABILITY"}, {"conceptId": "C49656", "definition": "A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition.", "preferredTerm": "Treatment Study", "submissionValue": "TREATMENT", "synonyms": ["Therapy Trial"]}, {"conceptId": "C161479", "definition": "A type of study designed to evaluate the user experience with a product.", "preferredTerm": "Usability Testing Study", "submissionValue": "USABILITY TESTING"}, {"conceptId": "C161480", "definition": "A type of study designed to evaluate the effects of water on investigational product safety and/or efficacy.", "preferredTerm": "Water Effect Trial", "submissionValue": "WATER EFFECT"}]}], "description": "CDISC Controlled Terminology for DDF is the set of CDISC-developed or CDISC-adopted standard expressions (values) used with data items within CDISC-defined DDF datasets.", "effectiveDate": "2023-12-15", "label": "DDF Controlled Terminology Package 56 Effective 2023-12-15", "name": "DDF CT 2023-12-15", "registrationStatus": "Final", "source": "DDF Controlled Terminology developed by the CDISC Terminology Team in collaboration with the National Cancer Institute's Enterprise Vocabulary Services (EVS)", "version": "2023-12-15"}
